|
BET1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53779997017034E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.21350000000542E-05 |
| Normal-vs-Stage2 |
6.452000E-02 |
| Normal-vs-Stage3 |
2.375100E-03 |
| Normal-vs-Stage4 |
1.423220E-03 |
| Stage1-vs-Stage2 |
1.734430E-01 |
| Stage1-vs-Stage3 |
4.848400E-02 |
| Stage1-vs-Stage4 |
1.479890E-02 |
| Stage2-vs-Stage3 |
6.315200E-01 |
| Stage2-vs-Stage4 |
5.767400E-01 |
| Stage3-vs-Stage4 |
9.003800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.06720001911287E-09 |
| Normal-vs-AfricanAmerican |
7.098500E-03 |
| Normal-vs-Asian |
1.037390E-01 |
| Caucasian-vs-AfricanAmerican |
4.468400E-01 |
| Caucasian-vs-Asian |
2.634400E-01 |
| AfricanAmerican-vs-Asian |
8.106000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.77520000313558E-08 |
| Normal-vs-Female |
3.010100E-04 |
| Male-vs-Female |
1.123410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.841500E-03 |
| Normal-vs-Extreme_Weight |
2.21629999996864E-06 |
| Normal-vs-Obese |
1.538170E-03 |
| Normal-vs-Extreme_Obese |
3.922200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.160800E-01 |
| Normal_Weight-vs-Obese |
1.911960E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.402400E-01 |
| Extreme_Weight-vs-Obese |
1.740840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.861770E-01 |
| Obese-vs-Extreme_Obese |
4.312000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.260300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.49349999537074E-08 |
| Normal-vs-Age(61-80Yrs) |
1.986440E-04 |
| Normal-vs-Age(81-100Yrs) |
3.384400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.254500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.146100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.129600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.056400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.482400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.791400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.84619999580249E-08 |
| Normal-VS-Type2 PRCC |
4.894500E-02 |
| Normal-VS-KIRP CIMP |
4.170100E-04 |
| Normal-VS-Unclassified PRCC |
1.801770E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.805600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.71479999977464E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
5.454400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.164400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.412200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.604210E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.841440E-03 |
| Normal-vs-N1 |
4.219800E-04 |
| Normal-vs-N2 |
5.133000E-01 |
| N0-vs-N1 |
1.160260E-02 |
| N0-vs-N2 |
4.956000E-01 |
| N1-vs-N2 |
1.496200E-01 |
|
|
